Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
vrtx
/
Vertex Pharmaceuticals Inc
VRTX
Add to Watchlist
473.290
USD
+0.720
+0.15%
Close 07-23 16:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
Pre-market 07/24, 09:30 (ET)
120.19B
Market Cap
27.83
P/E TTM
Vertex Pharmaceuticals Inc
473.290
+0.720
+0.15%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Capital World Investors
10.05%
Capital Research Global Investors
6.82%
Vanguard Capital Management, LLC
6.51%
BlackRock Institutional Trust Company, N.A.
6.00%
State Street Investment Management (US)
4.61%
Other
66.01%
Shareholders
Shareholders
Proportion
Capital World Investors
10.05%
Capital Research Global Investors
6.82%
Vanguard Capital Management, LLC
6.51%
BlackRock Institutional Trust Company, N.A.
6.00%
State Street Investment Management (US)
4.61%
Other
66.01%
Shareholder Types
Shareholders
Proportion
Investment Advisor
60.15%
Investment Advisor/Hedge Fund
28.02%
Pension Fund
2.27%
Research Firm
2.19%
Bank and Trust
2.05%
Sovereign Wealth Fund
1.33%
Hedge Fund
1.27%
Individual Investor
0.17%
Insurance Company
0.08%
Other
2.47%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
3075
247.47M
97.50%
-4.59M
2025Q4
2995
248.62M
97.99%
-4.56M
2025Q3
2933
249.27M
98.24%
-2.14M
2025Q2
2933
252.71M
98.56%
+2.47M
2025Q1
2977
252.24M
98.22%
-39.54K
2024Q4
2877
248.76M
96.87%
-2.25M
2024Q3
2786
247.87M
96.18%
-4.19M
2024Q2
2747
248.36M
96.27%
-4.14M
2024Q1
2680
247.63M
95.87%
-4.48M
2023Q4
2608
247.92M
96.20%
-4.51M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Capital World Investors
25.51M
10.04%
-400.40K
-1.55%
Dec 31, 2025
Capital Research Global Investors
17.32M
6.82%
+763.06K
+4.61%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
15.24M
6%
+768.21K
+5.31%
Dec 31, 2025
State Street Investment Management (US)
11.69M
4.6%
+83.54K
+0.72%
Dec 31, 2025
Geode Capital Management, L.L.C.
5.98M
2.35%
+8.16K
+0.14%
Dec 31, 2025
Invesco Capital Management (QQQ Trust)
5.40M
2.12%
-130.10K
-2.35%
Feb 28, 2026
Capital International Investors
4.73M
1.86%
+44.54K
+0.95%
Dec 31, 2025
JP Morgan Asset Management
4.54M
1.79%
+150.76K
+3.44%
Dec 31, 2025
View more
Related ETFs
Updated: Fri, Dec 5
Updated: Fri, Dec 5
Name
Proportion
VanEck Biotech ETF
9.71%
ProShares Ultra Nasdaq Biotechnology
8.83%
Invesco Nasdaq Biotechnology ETF
8.76%
iShares Biotechnology ETF
7.43%
Invesco Biotechnology & Genome ETF
5.35%
Natixis Loomis Sayles Focused Growth ETF
4.48%
First Trust NASDAQ Pharmaceuticals ETF
4.23%
First Trust NYSE Arca Biotechnology Index Fund
3.5%
Franklin Genomic Advancements ETF
3.33%
Simplify Health Care ETF
3.25%
View more
VanEck Biotech ETF
Proportion
9.71%
ProShares Ultra Nasdaq Biotechnology
Proportion
8.83%
Invesco Nasdaq Biotechnology ETF
Proportion
8.76%
iShares Biotechnology ETF
Proportion
7.43%
Invesco Biotechnology & Genome ETF
Proportion
5.35%
Natixis Loomis Sayles Focused Growth ETF
Proportion
4.48%
First Trust NASDAQ Pharmaceuticals ETF
Proportion
4.23%
First Trust NYSE Arca Biotechnology Index Fund
Proportion
3.5%
Franklin Genomic Advancements ETF
Proportion
3.33%
Simplify Health Care ETF
Proportion
3.25%